APA (7th ed.) Citation

Seethamraju, H., Yang, O. O., Loftus, R., Ogbuagu, O., Sammartino, D., Mansour, A., . . . Lalezari, J. P. (2024). A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19. Clinical therapeutics, 46(11), 891-899. https://doi.org/10.1016/j.clinthera.2024.08.019

Chicago Style (17th ed.) Citation

Seethamraju, Harish, et al. "A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19." Clinical Therapeutics 46, no. 11 (2024): 891-899. https://doi.org/10.1016/j.clinthera.2024.08.019.

MLA (9th ed.) Citation

Seethamraju, Harish, et al. "A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19." Clinical Therapeutics, vol. 46, no. 11, 2024, pp. 891-899, https://doi.org/10.1016/j.clinthera.2024.08.019.